MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-19-2026
DarioHealth Corp. Operating Expenses 2011-2026 | DRIO
Annual Operating Expenses DarioHealth Corp.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 49.3 M | 71 M | 62.2 M | 66.5 M | 80.5 M | 32.4 M | 20.3 M | 19.5 M | 15.7 M | 10.3 M | 6.84 M | 8.65 M | 13.6 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 80.5 M | 6.84 M | 35.1 M |
Quarterly Operating Expenses DarioHealth Corp.
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12.5 M | 12.2 M | 13.3 M | - | 15.9 M | 18.9 M | 20.3 M | - | 16.2 M | 16.1 M | 15.6 M | - | 16.4 M | 18.5 M | 19.9 M | - | 23.3 M | 19.5 M | 15.4 M | - | 7.15 M | 4.76 M | 10.9 M | - | 3.67 M | 5.69 M | 5.92 M | - | 4.52 M | 6.32 M | 3.47 M | - | 3.26 M | 4.48 M | 4.31 M | - | 2.8 M | 2.47 M | 1.82 M | - | 2.42 M | 1.28 M | 1.55 M | - | 1.92 M | 3 M | 2.25 M | - | 3.24 M | 3.6 M | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 23.3 M | 1.28 M | 9.07 M |
Operating Expenses of other stocks in the Diagnostics research industry
| Issuer | Operating Expenses | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
1.99 B | $ 115.93 | 0.34 % | $ 35.2 B |  USA |
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Co-Diagnostics
CODX
|
50.6 M | $ 1.67 | - | $ 2.22 M | USA |
 |
Aspira Women's Health
AWH
|
13.8 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
59.5 M | $ 25.24 | 3.19 % | $ 701 M | USA |
 |
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M |  Israel |
 |
CareDx, Inc
CDNA
|
411 M | $ 21.47 | 1.13 % | $ 1.14 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M |  Britain |
 |
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | USA |
 |
Illumina
ILMN
|
3.69 B | $ 127.5 | -0.3 % | $ 20.3 B | USA |
 |
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
2.47 B | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
181 M | $ 16.0 | -1.9 % | $ 484 M | USA |
 |
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M |  China |
 |
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
607 M | $ 173.04 | 1.93 % | $ 8.58 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | USA |
 |
Lantheus Holdings
LNTH
|
123 M | $ 84.45 | 0.14 % | $ 5.7 B | USA |
 |
Guardant Health
GH
|
226 M | $ 89.29 | 0.43 % | $ 11.2 B | USA |
 |
Medpace Holdings
MEDP
|
118 M | $ 415.78 | 1.28 % | $ 12 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
20 M | $ 1.91 | -3.29 % | $ 8.45 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
7.12 B | $ 27.59 | 0.42 % | $ 20 B |  Niderland |
 |
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K | Israel |
 |
Senseonics Holdings
SENS
|
61.8 M | $ 7.08 | 0.35 % | $ 295 M | USA |
 |
QIAGEN N.V.
QGEN
|
821 M | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
181 M | $ 52.73 | 0.01 % | $ 2.68 B | USA |
 |
Neogen Corporation
NEOG
|
1.48 B | $ 9.51 | -0.37 % | $ 2.06 B | USA |
 |
Biomerica
BMRA
|
5.64 M | $ 2.16 | 0.93 % | $ 4.96 M | USA |
 |
National Research Corporation
NRC
|
38.5 M | $ 17.21 | -0.12 % | $ 385 M | USA |
 |
ICON Public Limited Company
ICLR
|
408 M | $ 100.91 | -1.24 % | $ 8.32 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 263.12 | -0.24 % | $ 21.9 B | USA |
 |
Thermo Fisher Scientific
TMO
|
7.15 B | $ 467.91 | -0.35 % | $ 176 B | USA |
 |
Celcuity
CELC
|
172 M | $ 122.2 | 0.96 % | $ 5.71 B | USA |
 |
Trinity Biotech plc
TRIB
|
28.3 M | $ 0.64 | -1.51 % | $ 61.9 M | Irlanda |
 |
OpGen
OPGN
|
21.9 M | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
430 M | $ 8.54 | 3.02 % | $ 1.09 B | USA |
 |
Twist Bioscience Corporation
TWST
|
116 M | $ 60.33 | -1.0 % | $ 3.61 B | USA |
 |
Myriad Genetics
MYGN
|
964 M | $ 4.8 | 0.31 % | $ 444 M | USA |
 |
Natera
NTRA
|
258 M | $ 204.58 | 0.41 % | $ 20.1 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 196.1 | -0.06 % | $ 21.8 B | USA |
 |
Invitae Corporation
NVTA
|
343 M | - | - | $ 21.2 M | USA |
 |
PerkinElmer
PKI
|
1.07 B | - | -0.91 % | $ 14.7 B | USA |